Drug discovery company Kuano, announced the close of a £1.8 million seed funding round.
The company combines quantum mechanics with AI to design the next generation of medicines, focusing on seeing and modelling enzymes.
Dysfunctional enzymes are implicated in many human diseases.
Kuano raises £1.8M in seed funding round to accelerate quantum drug discovery. — Kuano